Corcept is a biopharmaceutical company leading the way in cortisol modulator research and development, dedicated to advancing the possibilities of cortisol modulation as a way to treat serious diseases.
Corcept is a biopharmaceutical company leading the way in cortisol modulator research and development. The Senior Director, Oncology Marketing will lead the launch of Corcept's first oncology product, relacorilant, in platinum resistant ovarian cancer. This role requires deep oncology expertise, strategic leadership, and a proven ability to translate customer insights into actionable strategies.
Corcept is a biopharmaceutical company leading the way in cortisol modulator research and development, dedicated to advancing the possibilities of cortisol modulation as a way to treat serious diseases.
Revolution Medicines